Abstract | Dividing cells that experience chromosome mis-segregation generate aneuploid daughter cells, which contain an incorrect number of chromosomes. Although aneuploidy interferes with the proliferation of untransformed cells, it is also, paradoxically, a hallmark of cancer, a disease defined by increased proliferative potential. These contradictory effects are also observed in mouse models of chromosome instability (CIN). CIN can inhibit and promote tumorigenesis. Recent work has provided insights into the cellular consequences of CIN and aneuploidy. Chromosome mis-segregation per se can alter the genome in many more ways than just causing the gain or loss of chromosomes. The short-and long-term effects of aneuploidy are caused by gene-specific effects and a stereotypic aneuploidy stress response. Importantly, these recent findings provide insights into the role of aneuploidy in tumorigenesis.
The term aneuploidy was coined by Gunnar Täckholm in 1922 (REF. 1 ). He studied the karyotypes of meiotic cells of first filial generation (F 1 ) hybrids from crosses between different rose species. He noted that, in meioses of a subset of these F 1 hybrids: bivalent and univalent chromosomes are not a multiple of seven [author's note: the haploid chromosome number of the genus Rosa]. In many instances this is also the case for their somatic karyotypes. Because it is necessary to coin a term for a chromosome number that is not a multiple of the base chromosome number, I will call this condition aneuploidy. Henceforth, aneuploidy refers to hyper and hypoploid chromosome numbers 1 
.
Aneuploidy is a frequent outcome of meioses in progeny of interspecies crosses, but it rarely arises during the mitotic divisions that form the soma and during meioses of intraspecies crosses. This is because surveillance mechanisms that prevent chromosome mis-segregation, such as the spindle assembly checkpoint (SAC; also known as the mitotic checkpoint) (BOX 1) , are in place [2] [3] [4] [5] [6] . Although these safeguard mechanisms are well characterized, the cellular consequences of their failure and what happens to cells that have become aneuploid because these safeguard mechanisms failed are only beginning to be understood.
The reason we lack a detailed understanding of the consequences of chromosome mis-segregation is that studying faulty chromosome segregation and the resultant aneuploidies is difficult. Chromosome mis-segregation is a rare event and hence difficult to capture. The analysis of the products of chromosome mis-segregation, cells with aneuploid genomes, is equally tricky. Studying small changes in gene dosage -chromosome gains or losses result in a 50% change in gene expression [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] -is difficult. Dissecting the complex consequences of hundreds, if not thousands, of such small changes in gene expression occurring simultaneously is even more challenging. However, with the development of increasingly sophisticated live-cell imaging tools and quantitative genomewide methods, we are beginning to make headway. We now appreciate that chromosome mis-segregation can have a dramatic effect on genome integrity, causing DNA damage and genomic rearrangements. We are also making progress towards understanding how an unbalanced karyotype affects cell and organismal physiology. It has now become clear that the phenotypes of a neuploid cells are composites of phenotypes caused by specific gene imbalances and general aneuploidy-associated traits caused by simultaneous changes in the gene dosag e of many genes, which have little effects when varied individually. Advances in understanding the immediate and long-term effects of chromosome mis-segregation are
Box 1 | Mechanisms that prevent chromosome mis-segregation
The process of chromosome segregation is tightly controlled by the spindle assembly checkpoint (SAC), an evolutionarily conserved surveillance mechanism that prevents the mis-segregation of chromosomes 5, 135 (see the figure) . When the sister kinetochores attach to microtubules emanating from only one spindle pole (syntelic attachment) or when only one of the two sister kinetochores attaches to microtubules (monotelic attachment), the SAC is activated and inhibits anaphase onset. When all kinetochores have attached to microtubules emanating from opposite poles (amphitelic attachment or bi-orientation), the SAC is silenced and anaphase commences (see the figure). Syntelic and monotelic microtubule-kinetochore attachments recruit core components of the SAC -mitotic arrest deficient 1 (MAD1), MAD2, BUB3, BUB1-related 1 (BUBR1) and the checkpoint kinases aurora B, BUB1 and monopolar spindle protein 1 (MPS1). The recruitment of these proteins catalyses the inhibition of the APC/C (anaphase-promoting complex, also known as the cyclosome)-CDC20 complex (APC/C CDC20 ), an E3 ubiquitin ligase that triggers the metaphase to anaphase transition (see the figure, left panels).
Inhibition of APC/C CDC20 is brought about by the incorporation of the APC/C activator CDC20 into the mitotic checkpoint complex (MCC), which is composed of the checkpoint proteins MAD2, BUBR1, BUB3 and CDC20 itself. When all kinetochores achieve amphitelic attachment, the SAC is turned off and APC/C CDC20 is activated. APC/C CDC20 then targets securin and cyclin B for degradation by the 26S proteasome. This leads to loss of sister chromatid cohesion and inactivation of cyclin-dependent kinase 1 (CDK1). These events trigger chromosome segregation and mitotic exit, respectively (see the figure, right panels).
A kinetochore that attaches to microtubules that emanate from both spindle poles is referred to as exhibiting a merotelic attachment, and this type of incorrect attachment is thought to be the major cause of aneuploidy in mammalian cells 136 . These types of kinetochore-microtubule attachments are not recognized by the SAC but instead are converted into amphitelic attachments through the action of aurora B and MPS1 kinases. The protein kinases convert merotelic attachments into amphitelic ones by destabilizing microtubule-kinetochore interactions through phosphorylation of outer kinetochore components.
C-M2, closed MAD2; KMN, KNL1-MIS12-NDC80 network; O-M2, open MAD2; Ub, ubiquitin. In this Review, we first discuss the detrimental effects of chromosome mis-segregation and aneuploidy on cell physiology. We describe recent findings that show that the process of chromosome mis-segregation has dramatic effects on genome integrity, causing DNA damage and activation of p53. We next summarize our current understanding of how an altered karyotype affects the cell's proteome and physiological state. We end with a discussion of links between chromosome mis-segregation, aneuploidy and cancer, reviewing recent evidence suggesting a causative role for chromosome mis-segregatio n and aneuploidy in tumorigenesis.
Aneuploidy is rare in normal tissues
When aneuploidy is present throughout the organism, it is known as constitutional aneuploidy. Such aneuploidies are caused by chromosome segregation errors during germ cell formation, usually during meiosis (reviewed in REF. 17 ). Somatic aneuploidy is the result of mitotic errors and describes a condition in which only some of cells in an organism harbour an abnormal karyotype. Most constitutional aneuploidies cause embryonic lethality, the most notable exception in humans being trisomy 21 (also known as Down syndrome). The consequences of having high levels of somatic aneuploidy are also severe. Patients with the rare human syndrome mosaic variegated aneuploidy (MVA), which is caused by mutations in (among others) BUB1B, a gene required for accurate chromosome segregation (reviewed in REF. 5) 
, exhibit growth retardation, microcephaly and childhoo d cancers 18 . Given the profound adverse effects of aneuploidy on human health, it is not surprising that cells with an unbalanced karyotype are rare. In budding and fission yeast, for example, the chromosome loss rate is estimated to be between 1 × 10 −5 and 1 × 10 −4 per generation [19] [20] [21] [22] ( these mis-segregation frequencies. Mouse lymphocytes and mouse and human keratinocytes exhibit aneuploidy frequencies of around 3% 25, 26 . However, mammalian brain and liver were reported to exhibit significantly higher levels of aneu ploidy. Fluorescence in situ hybridization (FISH) analyses suggested that as many as 50% of liver cells in humans are aneuploid [27] [28] [29] , and spectral karyotyping (SKY) 30 or FISH 25, [30] [31] [32] [33] studies reported 20-33% of brain cells are aneuploid. However, subsequent single-cell sequencing analyses contradicted these previous results and revealed that the brain and liver have low levels of aneuploidy, similar to those seen in other tissues 26, 34, 35 (TABLE 1) . The overestimation of aneuploidy by FISH and SKY is probably due to hybridization and chromosome-spreading artefacts, respectively. Furthermore, even a low frequency of artefacts for a singl e chromosome can lead to a gross overestimation of aneuploidy when extrapolated across all chromosomes.
Chromosome segregation defects are more frequent during meiosis, and their effects on reproductive success are significant (reviewed in REF. 17 ). In humans, approximately 35% of spontaneous abortions, 4% of stillbirths and as many as 25% of all zygotes are aneuploid 17, 36, 37 (TABLE 1).
Together, these observations indicate that constitutional and somatic aneuploidies are rare but, when they occur, their effect on health is dramatic. Below, we summarize our current understanding of how the immediate and long-term effects of chromosome mis-segregation cause decreased fitness, disease and even death.
Immediate effects of segregation errors
There are two consequences of chromosome missegregatio n: a faulty mitosis occurs and the resulting daughter cells are aneuploid. Recent studies indicate that both outcomes have a dramatic impact on cells.
Chromosome mis-segregation causes DNA damage. To understand the immediate consequences of chromosome mis-segregation, the frequency of chromosome mis-segregation events was increased by interfering with mitotic spindle function 38 . In such abnormal mitoses, mis-segregating chromosomes frequently lag behind during anaphase and can become trapped and damaged in the cleavage furrow during cytokinesis (FIG. 1) . The broke n chromosomes elicit a DNA-damage response. Their repair via non-homologous end-joining during the following G1 phase of the cell cycle can, but may not always, lead to translocations and deletions 38, 39 . Lagging chromosomes sometimes also do not catch up with the other chromosomes in time to be incorporated into the reforming nucleus. Such chromosomes then form their own micronuclei [40] [41] [42] [43] (FIG. 1) . These micronuclei are not just miniature nuclei, as they are not fully functional 39 . DNA replication proceeds slowly in micronuclei and results in abnormal and stalled replication forks 39, 43 . Given the importance of a functional nuclear envelope for efficient DNA replication 44 , defects in nuclear import [39] [40] [41] or irreversible nuclear envelope collapse 45 could be responsible for this inability of micronuclei to properly replicate their DNA (FIG. 1) . The consequences on DNA integrity are dramatic: levels of DNA damage are high in micronuclei, and repair of this damage leads to extensive DNA rearrangements 39, 46 , as elegantly demonstrated by combining live-cell-imagin g and single-cell-sequencing techniques 46 . The complex chromosomal rearrangements that form in micro nuclei are reminiscent of chromothripsis [47] [48] [49] , which has been observed in approximately 3% of cancers and is prevalent in osteosarcomas (35%) and aggressive neuro blastomas (18%) 48, 49 . Chromothripsis has also been observed in some human congenital diseases 50 , in which, as in cancer, it might provide the fuel for rapid genome evolution. figure) . b | Merotelic attachment, defined as a kinetochore that attaches to microtubules emanating from both spindle poles, can cause chromosomes to lag behind in the spindle midzone during anaphase. Such lagging chromosomes can have multiple fates. They can be trapped in the cytokinetic furrow and break during cytokinesis (top). Alternatively, they can form their own micronucleus, which is either accurately segregated (middle) or mis-segregated (bottom). Irrespective of how micronuclei are segregated, their DNA is poorly replicated and experiences significant damage in the subsequent cell cycle. 2N+x and 2N-x indicate aneuploid karyotypes in which an undefined number of chromosomes has been gained (+x) or lost (-x).
Chromothripsis
A process in which entire chromosomes become fragmented and then are repaired in a seemingly random manner, leading to dozens (sometimes even hundreds) of rearrangements within a single chromosome.
Chromosome mis-segregation causes p53 activation.
Errors in chromosome segregation result in p53 (also known as TP53) activation. Increased levels of p53 and expression of p53-responsive genes were detected following chromosome mis-segregation that resulted in G1 arrest 51 . Consistent with a role of p53 in causing the arrest, G1 arrest was alleviated by p53 inactivation. Moreover, p53 limits the proliferation of cells experiencing high levels of chromosome mis-segregatio n in the embryo. Mutant mice lacking the gene encoding the SAC component mitotic arrest deficient 2 (MAD2) die at embryonic day 6.5 (REF. 52 ). Similarly, Mad2 −/− mouse blastocysts die in culture within 5 days, but when p53 is deleted blastocysts remain viable for many weeks 53 . Thus, p53 plays a central part in the prevention of cell cycle progression following chromosome mis-segregation.
Which aspect of chromosome mis-segregation causes p53 activation remains a key unanswered question, for which consensus has not yet been reached. One study 38 suggested that DNA damage during cytokinesis causes p53 activation (FIG. 2a) . However, in another study 51 , DNA damage following chromosome mis-segregation was not detected, and it was proposed that aneuploidy per se activates p53 (FIG. 2b) . Similarly, another group 54 observed p53 activation but not DNA damage in SACdeficient mouse embryonic fibroblasts (MEFs). Instead, this group reported that reactive oxygen species (ROS) were elevated following chromosome mis-segregation. High levels of ROS caused activation of the DNA damage checkpoint kinase ataxia-telangiectasia mutated (ATM) and p53 (FIG. 2c) . It is noteworthy that increased levels of ROS have also been observed in aneuploid buddin g yeast strains 11 .
What could be the reason for these different results? DNA damage occurring during chromosome missegregatio n is likely to be transient and could have been missed in some studies. Differences in experimental procedures could also determine whether p53 is activated. Some approaches used to generate aneuploid cells involve arresting cells in prometaphase for prolonged periods of time. Arresting cells in prometaphase for more than 90 minutes causes a p53-dependent G1 arrest when cells are released from the cell cycle block, irrespective of whether chromosomes have been mis-segregate d 55 . The mechanisms whereby prometaphase length causes p53 activation are not understood, but multiple events could contribute (FIG. 2d) . Prolonged prometaphase arrest causes apoptosis and hence a DNA-damage response 56 , telomere uncapping 57 , p38 activation 55 and a decrease in double minute 2 (MDM2) levels, which targets p53 for degradation [58] [59] [60] . All these events could lead to p53 activation.
In summary, which aspects of chromosome missegregation -there could be multiple -activate p53 remains to be clearly defined. Interestingly, p53 activation has not been observed in cells with constitutional aneuploidies 61 , which suggests that p53 activation is an immediate consequence of chromosome missegregatio n and is attenuated in cells with constitutional aneuploidies or is only elicited by specific aneuploid karyotypes.
Long-term effects of having an altered karyotype Changes in chromosome composition cause numerous phenotypes and have long-term effects. The reason is that changes in the copy number of genes located on autosomes largely, although not universally, result in a corresponding change in gene expression. A systematic . 2N+x and 2N-x indicate aneuploid karyotypes in which an undefined number of chromosomes has been gained (+x) or lost (-x). b | Aneuploidy per se causes activation of p53 through p38 by an unknown mechanism 51 . c | Aneuploidy causes metabolic changes that lead to an increase in reactive oxygen species (ROS). ROS activate the DNA damage checkpoint kinase ataxia-telangiectasia mutated (ATM), which in turn activates p53 (REF. 54 ). d | Prolonged mitotic arrest causes p53 activation. When cells are arrested in prometaphase for more than 1.5 hours, cells activate p53 on release from the prometaphase block 55 . How p53 activation occurs is not understood but could result from partial activation of apoptosis, telomere uncapping (through the loss of telomere-capping protein telomeric repeat-binding factor 2 (TRF2)), p38 activation or double minute 2 (MDM2) downregulation that occur during prolonged mitotic arrest 57 . Ub, ubiquitin.
Dosage compensation
Alteration of mRNA or protein expression to compensate for variation in DNA copy number.
analysis of budding yeast strains carrying single additional chromosomes showed that approximately 80% of genes that are present in an additional copy are expressed at an accordingly increased level 11 . The genes that do not show increased expression predominantly encode proteins that function in multi-protein complexes, such as the ribosome 11 . Similar observations were made in fission yeast, Arabidopsis thaliana and mammalian cells 10, 12, 13, 15, 16, [62] [63] [64] [65] [66] , but the principle that gene copy number determines the abundance of gene product may not be universal. Mechanisms of dosage compensation, such as those described for sex chromosomes, may exist for autosomes in Drosophila melanogaster and in some plants [67] [68] [69] [70] [71] . Which aspects of gaining and losing whole chromosomes cause the phenotypes observed in aneuploid cells and organisms? Although studies in budding yeast have shown that the presence of five additional centromeric plasmids interferes with microtubule-kinetochore attachment 72 , gaining or losing DNA per se is generally not considered the major cause for phenotypic changes associated with aneuploidy. This was demonstrated by introducing large amounts of mammalian DNA into budding yeast cells. The finding that in budding yeast all aneuploidyassociated phenotypes analysed to date are attenuated by increased ploidy 14, 73 further indicates that it is relative levels of gene dosage that are mainly responsible for the phenotypes associated with an altered karyotype. Phenotypes caused by the gain of single chromosomes are drastically attenuated in diploid yeast cells compared to haploid yeast cells 14, 73 . Thus, polyploidy represents an aneuploidy-tolerating condition. This is illustrated by the observation that tetraploid yeast strains exhibit a 200-fold increase in chromosome loss compared to diploid yeast strains, but proliferation is only mildly impaired 22 . In cancers too, an increase in genomewide ploidy (many cancers are tetraploid) probably protects cancer cells from the adverse effects of aneuploidy, allowing them to take advantage of potential beneficial traits conferred by altered dosage of specific oncogenic drivers.
Below, we provide examples of how changes in the copy number of specific genes (gene-specific effects) interfere with development and cause diseases. We then describe how simultaneously changing the copy number of many genes that on their own have little effect on cellu lar functions causes a generic set of phenotypes known as aneuploidy-associated stresses.
Gene-specific effects of aneuploidy Changes in gene copy number have been linked to many diseases (reviewed in REFS 74, 75) . For example, duplication of the APP gene (encoding amyloid-β precursor protein) has been implicated in early onset Alzheimer disease 76 , and deletion of one copy of PMP22 (the gene encoding peripheral myelin protein 22) is the cause of CharcotMarie-Tooth 1A neuropathy 77 . Although examples of changes in gene copy number causing developmental abnormalities and diseases are numerous, dramati c effects of gaining or losing single genes on cellular fitness are less common. The best-known example is the β-tubulin gene in Saccharomyces cerevisiae: having an additional copy of this gene is lethal 78 . Only a handful of other genes have been shown to reduce fitness when present in an additional copy under standard growth conditions 79 . Similarly, only few genes were found to reduce fitness when present in one copy instead of two. In budding yeast, only 184 genes (3% of the yeast genome) are haploinsufficient for growth under optimal growth conditions 80 . This number is higher in fission yeast 81 (455 genes), most likely because fission yeast predominantly propagates as a haploid, whereas budding yeast propagates as diploid, which presumably causes haploinsufficienc y to be under strong negative selection 81 . Understanding how changes in the gene dosage of individual genes affect development and organismal functions will be important for developing strategies to improve the lives of individuals with Down syndrome. Two recent studies suggest that some of the defects caused by an additional copy of chromosome 21 are reversible. It was found that the cognitive deficiencies in mouse models of Down syndrome can be ameliorated by a Hedgehogagonist therapy 82 . Silencing one copy of chromosome 21 by targeting the X chromosome-inactivatin g long noncoding RNA X-inactive specific transcript (Xist) to one of the three copies of this chromosome greatly improved proliferation and neural rosette formation in pluripotent Down syndrome stem cells 83 . These findings open potential new avenues for the development of therapies for the treatment of Down syndrome.
Aneuploidy-associated stresses A 50% change in expression of the majority of genes individually has little, if any, effect on cellular fitness. By contrast, the same change in dosage of many such genes simultaneously contributes to the decrease in fitness of cells with unbalanced karyotypes and is responsible for traits shared by cells with different aneuploidies 84 (FIG. 3) .
We refer to these general traits as aneuploidy-associated stresses. Thus far, they have been studied only in cellular models of aneuploidy, but they probably contribute to the numerous phenotypes observed in aneuploid organisms.
Transcriptional and post-transcriptional responses.
Studies of aneuploid budding yeast, fission yeast and plants, as well as of aneuploid primary, untransformed mouse and human cells, have revealed a conserved gene expression response to the aneuploid state 14, [85] [86] [87] (FIG. 3) .
Transcripts associated with cell growth, proliferation and nucleic-acid metabolism are downregulated, while Chromosomal instability (CIN) . A condition in which the rate of chromosome mis-segregation is elevated.
Proteotoxic stress
A cellular stress elicited by unfolded and/or misfolded proteins.
transcripts associated with stress and membrane functions are upregulated. These transcriptional alterations are reminiscent of the environmental-stress response (ESR), which was first described in budding yeast 88, 89 (FIG. 3) . The ESR is triggered by several stresses and/or slowed growth, and the gene expression pattern commonly observed in aneuploid cells is probably the result of cellular stress as well as a reflection of the sluggish proliferation of aneuploid cells 85, 87 . In cancers, some transcripts have been found to be more abundant in cancers with a high degree of aneuploidy 90 . A gene expression signature derived from this study (known as CIN70) had been proposed to function as a marker of chromosomal instability (CIN) in cancer. However, subsequent research has demonstrated that CIN70 more accurately reflects the proliferation rate of tumours, rather than intrinsic CIN 91, 92 . A comparison of high-CIN and low-CIN cancer cell lines identified a set of transcriptional changes distinct from CIN70 but similar to the ESR observed in primary aneuploid cells. Interestingly, an ESR was not observed when comparing the transcriptomes of highly aneuploid breast tumours with those of near-diploid breast tumours. These findings led to the proposal that two types of aneuploidy exist in cancers: 1) continuously changing karyotypes that, like aneuploidies in primary cells, have a negative impact on cellular fitness; and 2) selected, stable aneuploid karyotypes that have evolved to support maxima l proliferation and in which the stresses caused by aneuploid karyotypes are suppressed. It is important to note that the gene expression changes caused by CIN in cancer and by aneuploidy in primary cells are related but not identical. For example, genes annotated to the mitotic cell cycle are very strongly downregulated in trisomic fibroblasts, whereas in high-CIN cancer cell lines, cell cycle genes are moderately downregulated but RNA metabolism genes are strongly suppressed. The cause of these differences is unknown at present. Recently, an additional gene expression signature shared among aneuploid budding yeast strains was identified 11 . This signature, named the aneuploidy-associated protein signature (APS), is characterized by the upregulation of proteins but not transcripts of genes involved in the oxidative-stress response. The strength of the APS correlates with the degree of aneuploidy, suggesting that a higher degree of karyotype imbalance causes an increase in ROS. Which aspect of the aneuploid condition is responsible for elevated ROS remains to be determined. However, hyper-activation of the proteasome, through inactivation of the proteasome-associated deubiquitylating enzyme ubiquitin carboxyl-terminal hydrolase 6 (UBP6) suppresses the APS 11 , raising the interesting possibility that proteotoxicity, a hallmark of the aneuploid state (discussed below), contributes to the APS (FIG. 3) .
Aneuploidy causes proteotoxic stress. In healthy cells, a complex regulatory network maintains cellular protein homeostasis (proteostasis) by ensuring that proteins are present only in their fully active form and at appropriate levels 93, 94 . Chaperone-mediated folding pathways facilitate the folding of proteins; protein degradation pathways -autophagy and the ubiquitin proteasome system
-ensure that misfolded proteins are eliminated (reviewed in . When these systems become limiting or are impaired, unfolded and misfolded proteins accumulate, resulting in proteotoxic stress (FIG. 4) . This stress is met by a multi-pronged response aimed at increasing the protein quality control capacity of the cell.
Aneuploidy affects all protein quality control pathways in the cell. Analysis of budding yeast strains carrying single additional chromosomes (disomic strains) showed that at least one chaperone, Hsp90 (reviewed in REF. 100 ), is limiting in several different disomic yeast strains 73 . Aneuploid immortalized and tumorigenic human cells 101 are also defective in HSP90-mediated protein folding. Reduced protein folding capacity was suggested to be caused by a reduced ability to activate a heat Figure 3 | Aneuploidy-associated stresses. The aneuploid state elicits several cellular responses. Proteotoxic and energy stress have been proposed to cause activation of the aneuploidy-associated protein signature (APS), which involves the upregulation of proteins required for oxidative-stress response and energy homeostasis. Aneuploidy also leads to slowed proliferation and an associated environmental-stress response (ESR)-like response, in which stress-response genes are upregulated and cell proliferation genes are downregulated. Additionally, aneuploid cells activate p53, leading to impaired proliferation or apoptosis. This could be the result of genomic instability and activation of the DNA damage kinase ataxia-telangiectasia mutated (ATM), activation of the stress kinase p38, prolonged cell cycle arrest, altered energy homeostasis or a combination thereof. AU, arbitrary unit; ROS, reactive oxygen species. Conversely, it was found that basal levels of expression of the HSF1 target HSP72 (also known as HSPA2) were increased in aneuploid MEFs 61 . Primary mouse cells may respond differently to folding stress than immortalized and cancerous human cell lines. Despite these differences, all types of mammalian cell lines carrying one or two additional chromosomes analysed to date are more sensitive than euploid cells to the HSP90 inhibitor 17-N-allylamino-17-demethoxygeldanamycin (17-AAG) 61, 101 , indicating that HSP90 is limiting in severa l aneuploid cells.
Aberrant karyotypes also affect protein degradation pathways, including ubiquitin-mediated proteasomal degradation of short-lived proteins and autophagy-mediated removal of protein aggregates. Some disomic budding yeast strains exhibit sensitivity to the proteasome inhibitor MG132 (REF. 14). Furthermore, hyper activation of proteasomal degradation by deletion of the proteasome-associated deubiquitylating enzyme UBP6 attenuates the aneuploidy-induced changes in cellular protein composition and improves cell fitness 11, 63 . Unlike some disomic budding yeast strains, mammalian aneuploid cells do not exhibit increases sensitivity to proteasome inhibitors 61 . Recent studies indicate that p roteasomemediated degradation is increased in aneuploid mammalian cells 101 , suggesting that proteasome activity is upregulated in cells with abnormal karyotypes 101 . Conversely, autophagy seems to be insufficient in aneuploid mammalian cells. Trisomic MEFs and aneuploid human cells exhibit increased sensitivity to the lysosome inhibitor chloroquine 10, 61 . Furthermore, the gene expression signature of aneuploid human cells is similar to that of cells in which lysosomal degradation is inhibited 87 . Our research indicates that autophagosomes accumulate within lysosomes without evidence of lysosome malfunction (S.S. and A.A., unpublished observations). It thus seems that autophagy is a major route of clearance of misfolde d proteins in aneuploid mammalian cells.
Why is proteotoxicity a universal feature of aneuploid cells? The comparison of haploid yeast strains carrying an additional chromosome (disomic strains) with diploid yeast strains carrying an extra copy of the same chromosome (trisomic strains) provided insight into this question. All phenotypes indicative of proteotoxic stress are greatly reduced in trisomes compared to in disomes, suggesting that changes in the relative ratio of proteins are a major source of proteotoxicity in aneuploid cells. In haploid cells, an extra copy of a gene leads to a doubling of gene expression. In diploid cells, the relative increase or decrease in expression is only 50%. Although this difference may be of little consequence for proteins
Box 2 | Cellular protein quality control
Proteins must adopt a defined three-dimensional structure to be functional. A complex network of chaperone systems ensures that polypeptides reach their functional conformation. However, even after adopting the folded conformation, proteins are at risk of unfolding because the energy barrier between folded and unfolded or misfolded conformations is not insurmountable. Stress conditions or intrinsic instability can further contribute to protein misfolding.
Misfolded proteins either re-engage chaperones to reattempt correct folding or are degraded. Degradation is mediated by ubiquitin-mediated proteasomal degradation. The concerted functions of E1, E2 and E3 enzymes leads to ubiquitylation of the misfolded protein, thereby targeting the misfolded protein for degradation by the proteasome 98, 99 (see the figure, top) .
When folding load exceeds chaperone capacity and/or when the ubiquitin-proteasome system is compromised, misfolded or unfolded proteins can form aggregates. Such aggregates are cleared by autophagy. Deubiquitylating enzymes (DUBs) and E3 ubiquitin ligases remodel ubiquitin chains (which can involve either the Lys48 or the Lys63 residue of ubiquitin), which are then able to bind ubiquitin receptors, such as sequestosome 1 (also known as p62) and NBR1 (REF. 98 ). Autophagosomal membranes then form around the ubiquitylated aggregates 98 . When encapsulated into autophagosomes, protein aggregates are delivered to lysosomes, where they are degraded (see the figure, bottom). that fold spontaneously, it has profound consequences for proteins that require chaperones to reach their native conformation. Many protein complex subunits are unstable unless bound to their partners and will often bind to chaperones to remain soluble until they associate with their binding partners 102 . Thus, in aneuploid cells, every single subunit produced from the additional gene copy will require the continuous engagement of chaperones to remain in a soluble state and will eventually need to be degraded when a binding partner cannot be found. This is illustrated by the analysis of the proteome of aneuploid cells. In disomic budding yeast strains, approximately 20% of proteins do not exhibit increased expression when gene dosage is doubled, even though transcript levels are upregulated according to gene copy number 13, 63 . The vast majority of proteins whose expression does not scale with gene number are subunits of multi-protein complexes 10, 11, 14, 63 . The ribosome is especially worth mentioning in this context. Increasing the copy number of ribosomal genes does not lead to a corresponding increase in protein levels 11 . Given that ribosomal proteins constitute approximately 20% of the total protein content in yeast eliminating ribosomal subunits produced from excess gene copies alone could place a burden on the cell's protein quality control pathways.
Autolysosome
At first glance, it may seem surprising that changing the expression of genes by 50% challenges the cell's protein quality control pathways. Granted, gaining or losing whole chromosomes causes changes in the expression of hundreds (sometimes thousands) of genes, but why does the cell not simply continuously increase protein quality control activity, as occurs during heat shock?
The inability of cells to adapt to the aneuploid state could be explained by a recently discovered feature of gene expression control: the expression of subunits that assemble into a complex is coordinated 103 . This indicates that, rather than maintaining a large protein quality control reservoir to keep a large pool of unassembled protein complex subunits in a soluble state, cells have evolved to minimize the need for protein quality control pathways to assemble complexes. When subunits of complexes are continuously produced in the incorrect stoichiometries, as occurs in aneuploid cells, the protein quality control pathways of the cells are challenged, and proteotoxic stress ensues.
Aneuploidy inhibits cell proliferation. Decreased proliferation is another characteristic of aneuploid cells 10, 13, 14, 16, 51, 54, [104] [105] [106] [107] . Aneuploid fission yeast strains derived as progeny from triploid meioses delay in G1 (REF. 104 ). Haploid budding yeast strains disomic for one or two chromosomes or harbouring complex aneuploidies proliferate slowly, and many such strains also show a G1 delay 14, 106 . Chromosome mis-segregation and aneuploidy also interfere with proliferation in mammalian cells. MEFs harbouring hypomorphic mutations in the SAC gene BUB1-related 1 (BUBR1) 107 , mutations in the SAC target CDC20 that render it insensitive to checkpoint regulation 54 , or mutations that interfere with the chromosome segregation process (through depletion of the kinesin MCAK or on monastrol washout) exhibit proliferation defects. Some mutations that increase chromosome mis-segregation (for example, cells heterozygous for a have not been reported to decrease cell proliferation. This could be due to the fact that only a small fraction of cells in the population mis-segregate chromosomes, causing the ensuing proliferation defect to be subtle and thus missed. Proliferation defects are also observed in cells harbouring constitutive aneuploidies. Trisomy 21 human fibroblasts and MEFs trisomic for chromosome 1, 13, 16 or 19 divide more slowly than normal cells, although a specific cell cycle delay could not be identified 16 . However, other trisomic human cells show a G1 delay 10 , indicating that, as in yeast, G1 delay is a common occurrence in aneuploid mammalian cells.
An important question regarding the proliferation defects of aneuploid cells is whether they are the consequence of copy number changes of a few especially harmful genes or of many genes that cause no growth defect when varied individually. As with most, if not all, aneuploidy-associated phenotypes, the answer is likely to be that both contribute. For example, having a single additional copy of chromosome 6 causes lethality in haploid budding yeast cells because having a single additional copy of the β-tubulin-encoding gene TUB2 is lethal 78 . However, such cases are rare, at least in budding yeast. A genome-wide study in budding yeast determined the upper copy number limit of every gene in the budding yeast genome and identified 55 genes that are not tolerated at more than 5 copies per haploid genome 110 . However, changes in the copy number of these most dosage-sensitive genes are insufficient to drive the proliferation defects of aneuploid cells 84 . Introducing an additional copy of these dosage-sensitive genes into yeast strains did not recapitulate the growth defects of yeast strains carrying an additional copy of the chromosome the genes are located on. This finding indicates that the proliferation defects of aneuploid budding yeast cells are largely caused by simultaneous gene copy number changes that independently are benign, at least under standard growth conditions. So, if it is not only individual genes that at altered dosage impair proliferation in aneuploid cells, which other aspects of the aneuploid condition also affect proliferation? Aneuploidy-induced proteotoxicity seems to contribute to the proliferation defect of aneuploid cells. In budding yeast, increasing protein quality control improves not only protein homeostasis but also cellular fitness. Deleting UBP6 improves proliferation in 11 out of 13 disomic yeast strains under conditions of heat stress (growth at 37 °C) 11 . In mammalian cells, increased chaperone expression also improves fitness. Overexpression of the heat shock transcription factor HSF1 rescues not only the folding defect of human aneuploid cells but also their proliferation defect 101 . Although other aspects of HSF1 biology that are beyond its role in protein folding might contribute to improved proliferation of aneuploid cells on HSF1 overexpression, this remarkable finding points to a link between aneuploidy-induced proteotoxicity and proliferation defects 101 . Whether other aneuploidyassociated stresses contribute to the reduced proliferative abilities of aneuploid cells remains to be determined.
Aneuploidy in cancer 90% of solid tumours and 50% of blood cancers are aneuploid 111, 112 . Whether and how aneuploidy promotes tumorigenesis has been an active area of research and discussion. The realization that mutations in genes regulating chromosome segregation are rare in cancers [113] [114] [115] , together with the observation that aneuploidy inhibits proliferation, suggests that aneuploidy is a by-product of tumorigenesis that interferes with the process rather than causes it. Indeed, loss of tumour suppressors has been shown to cause CIN. RB inactivation not only deregulates the G1-S phase transition but also compromises centromere function, which leads to CIN and hence aneuploidy 116, 117 . Loss-of-function mutations in adenomatous polyposis coli (APC) cause deregulation of the WNT pathway and decrease chromosome segregatio n fidelity 118 . Although aneuploidy can be a by-product of oncogenic transformation, there is mounting evidence that aneuploidy can promote tumorigenesis. Analysis of cancer genomes indicates that loss of tumoursuppresso r genes and gain of oncogenes drives karyotype changes, such as whole or partial chromosome gains and losses, creating the clonal aneuploid karyotypes characteristic for a specific cancer 119 . However, the analysis of specific aneuploid karyotypes and mouse models of CIN revealed that aneuploidy can both promote and inhibit tumorigenesis. Mice trisomic for part of chromosome 16 are resistant to APC multiple intestinal neoplasia (Apc Min ) mutation-induced colon cancer 120 . Individuals trisomic for chromosome 21 are less likely to develop solid tumours than the euploid population 121 . This tumour-protective function of trisomy 21 has been attributed to the triplication of the Down syndrome critical region 1 (DSCR1) gene 122 . Conversely, trisomy 8 seems to promote haematopoietic malignancies. 25% of chronic myeloid leukaemias (CMLs), 10-15% of acute myeloid leukaemias (AMLs) and 5% of acute lymphoblastic leukaemias (ALLs) harbour an additional copy of chromosome 8 (REF. 123 ). MYC, a key driver of haematopoietic malignancies, is located on chromosome 8 and could be the reason for the prevalence of additional copies of chromosome 8 in blood cancers 124 . Studies of mouse models of CIN (Supplementary information S1 (table)), the condition that spawns aneuploid karyotypes, also show that, akin to other forms of genomic instability, such as reduction of telomerase activity 125, 126 , CIN can promote and inhibit tumorigenesis. A prime example for this dual role of CIN in tumorigenesis is the motor protein CENPE 108 . Animals heterozygous for a CENPE deletion harbour increased levels of aneuploidy 108 and are significantly less likely to develop spontaneous liver tumours and 7,12-dimethylbenz(a)anthracene (DMBA)-induced tumours 108 (see also Supplementary information S1 (table) ). However, the same animals exhibit an increase in the incidence of spleen lymphomas and lung adenomas 108 . Many other mouse models of CIN have been described to promote or inhibit tumorigenesis in a manner that depends on the cell type and genetic background in which the abnormal karyotype arises (summarized in Supplementary information S1 (table)) .
Recent studies revealed a perhaps general principle whereby aneuploidy can promote tumorigenesis 127 . In a KRAS-driven model of lung cancer, continuous KRAS expression is required for tumour maintenance. On repression of KRAS, tumours regress. When chromosome mis-segregation is induced in KRAS-driven tumours through the overexpression of the SAC factor MAD2, the disease relapses quickly. This finding suggests that the karyotype heterogeneity created by increased CIN facilitates the emergence of KRAS-independent tumours 127 . Although increased karyotypic instability can facilitate the evolution of advantageous karyotypes, it of course is much more likely to generate disadvantageous ones. A recent study 128 illustrates this double-edged nature of CIN. Mice lacking one copy of CENPE exhibit an increase incidence of spleen and lung tumours. Increasing chromosome mis-segregation in these mice by interfering with SAC function decreased tumour formation by increasing cell death 128 . These findings indicate that low rates of chromosome mis-segregation can promote tumorigenesis by increasing the likelihood of generating a tumour-promoting karyotype. However, when chromosome mis-segregation rates become too high, tumour cells cannot 'hold on' to such t umorigenesis-promoting karyotypes. Instead, cells with inviable karyotypes are continuously generated, leading to cell death and hence tumour suppression.
Conclusions and future directions
Research over the past 5 years has provided significant insights into the immediate and long-term consequences of chromosome mis-segregation and has provided concrete hypotheses for how CIN and aneuploidy could promote tumorigenesis. Chromosome mis-segregation can lead to structural alterations of chromosomes. These alterations and the genomic instability that arises from the aneuploid state per se 129, 130 are probably drivers of tumour evolution. We now also understand that aneuploid karyotypes negatively affect cellular fitness but rare favourable variants can provide a survival advantage, as has been seen in microbial evolution studies [131] [132] [133] . Understanding how certain karyotypes promote specific aspects of tumorigenesis will be an important next step in understanding the role of aneuploidy in tumorigenesis. Whether the gene-specific phenotypes and general stresses caused by the aneuploid state can be exploited in cancer therapy should also be determined. Synthetic negative interactions between proteotoxic and energy-stress inducing compounds and aneuploidy have been described 61 . Strategies that first select for a specific karyotype to then eliminate it have been reported recently in inhibiting the growth of aneuploid fungal pathogens and several central nervous system cancer cell lines 134 . Aneuploidy is a hallmark of cancer yet is rare in normal tissues. Compounds that target the aneuploid state therefore have ideal therapeutic properties: broad-spectrum efficacy and high specificity. A large-scale effort is now required to identify such compounds.
